Arrowhead Pharmaceuticals Inc.

NASDAQ:ARWR

16.79

-0.11 (-0.65%)

4:20:00 PM EDT: $16.79 0.00 (0.00%)

Market Cap (Intraday)	2.30B
Current PE	N/A
Forward PE	83.95
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$46.83 Million
Adjusted EPS	-$0.95

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Arrowhead Pharmaceuticals Inc. Stock, NASDAQ:ARWR

177 East Colorado Boulevard, Suite 700, Pasadena, California 91105

United States of America

Phone: +1.626.304.3400

Number of Employees: 609

http://www.arrowheadpharma.com

Description

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.